Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
J Diabetes Sci Technol. 2023 May;17(3):733-741. doi: 10.1177/19322968231161076. Epub 2023 Mar 22.
There has been a significant increase in the use of wearable diabetes technologies in the outpatient setting over recent years, but this has not consistently translated into inpatient use.
An online survey was undertaken to understand the current use of technology to support inpatient diabetes care in the United Kingdom.
Responses were received from 42 different organizations representing 104 hospitals across the United Kingdom. Significant variation was found between organizations in the use of technology to support safe, effective inpatient diabetes care. Benefits of the use of technology were reported, and areas of good practice identified.
Technology supports good inpatient diabetes care, but there is currently variation in its use. Guidance has been developed which should drive improvements in the use of technology and hence improvements in the safety and effectiveness of inpatient diabetes care. Key recommendations include implementation of this guidance (especially for continuous glucose monitoring), ensuring specialist support is available for the use of wearable diabetes technology in hospital, optimizing information sharing across the health care system, and making full use of data from networked glucose and ketone meters.
近年来，可穿戴糖尿病技术在门诊环境中的使用显著增加，但这并未一致转化为住院使用。
我们进行了一项在线调查，以了解英国目前使用技术支持住院糖尿病护理的情况。
来自英国 104 家医院的 42 个不同组织的回复。在使用技术支持安全、有效的住院糖尿病护理方面，各组织之间存在显著差异。报告了使用技术的好处，并确定了良好的实践领域。
技术支持良好的住院糖尿病护理，但目前技术的使用存在差异。已经制定了指导意见，应推动技术的使用改进，从而提高住院糖尿病护理的安全性和有效性。关键建议包括实施该指南（特别是连续血糖监测），确保为医院使用可穿戴糖尿病技术提供专业支持，优化整个医疗保健系统的信息共享，并充分利用联网血糖和酮体计的数据。
